By carrying anti-PD-L1 nanobodies or binding with anti-CD73 antibodies, exosomes derived from M1 TAMs acquire the ability to reverse tumor immune suppression and increase the sensitivity of tumor cells to radiation therapy [103, 104]. The gene discussed is NT5E; the disease is neoplasm.